This paper deals with the issue of how to determine the treatments to be perscribed to patients that are cost effective. This paper deals with the specific issue of Mr. H. who is a hemophiliac. He has a very rare version of the disease that cannot tolerate factor VIII. Recently a new procedure has arisen that is risky, 30% effective and cost $5 Million, as compared to factor VIII which is $100,000 a year. He is crippeled without this procedure but he doesn't have inusurance should socialized medicine pay for his procedure or not?